HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sture Lindegren Selected Research

Astatine

3/2016Synthesis and Evaluation of Astatinated N-[2-(Maleimido)ethyl]-3-(trimethylstannyl)benzamide Immunoconjugates.
7/2015Automated astatination of biomolecules--a stepping stone towards multicenter clinical trials.
12/2009Glomerular filtration rate after alpha-radioimmunotherapy with 211At-MX35-F(ab')2: a long-term study of renal function in nude mice.
9/2003(211)At-labeled and biotinylated effector molecules for pretargeted radioimmunotherapy using poly-L- and poly-D-Lysine as multicarriers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sture Lindegren Research Topics

Disease

39Neoplasms (Cancer)
04/2024 - 05/2002
19Ovarian Neoplasms (Ovarian Cancer)
01/2021 - 09/2003
7Carcinoma (Carcinomatosis)
01/2017 - 10/2007
6Ascites
12/2017 - 11/2005
4Body Weight (Weight, Body)
02/2020 - 04/2013
3Neoplasm Metastasis (Metastasis)
01/2022 - 08/2014
2Prostatic Neoplasms (Prostate Cancer)
02/2024 - 02/2020
2Ovarian Epithelial Carcinoma
01/2023 - 01/2019
2Residual Neoplasm
02/2020 - 11/2015
2Neoplasm Micrometastasis
08/2013 - 09/2003
1Intestinal Perforation
01/2019
1Fatigue
01/2019
1Breast Neoplasms (Breast Cancer)
10/2016
1Weight Loss (Weight Reduction)
04/2013
1Disease Progression
03/2013

Drug/Important Bio-Agent (IBA)

13Monoclonal AntibodiesIBA
04/2023 - 03/2003
12Astatine-211IBA
04/2024 - 10/2007
7211At-labeled monoclonal antibody MX35IBA
01/2021 - 08/2006
7AntibodiesIBA
01/2021 - 09/2003
5Radioisotopes (Radionuclides)IBA
01/2018 - 07/2011
4AstatineIBA
03/2016 - 09/2003
3Immunoconjugates (Immunoconjugate)IBA
03/2016 - 12/2005
2Neoplasm Antigens (Tumor Antigens)IBA
04/2023 - 01/2015
2AntigensIBA
02/2020 - 01/2019
2EpitopesIBA
01/2015 - 09/2003
2Lysine (L-Lysine)FDA Link
12/2011 - 05/2002
1SolutionsIBA
01/2024
1Colloids (Colloid)IBA
01/2023
1Contrast MediaIBA
01/2023
1Thorium Dioxide (Thorotrast)IBA
01/2023
1farletuzumabIBA
01/2021
1Rituximab (Mabthera)FDA Link
01/2021
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
02/2020
1Indicators and Reagents (Reagents)IBA
01/2019
1tanespimycin (17AAG)IBA
10/2016
1TinIBA
03/2016
1Reducing AgentsIBA
08/2014
1HalogensIBA
08/2014
1BR96 monoclonal antibodyIBA
08/2014
1Lutetium-177IBA
08/2014
1Hematoxylin (Haematoxylon)IBA
08/2013
1Eosine Yellowish-(YS) (Eosin)IBA
08/2013
1Lewis Y antigenIBA
04/2013
1procaine isothiocyanate (PRIT)IBA
03/2013
1AvidinIBA
12/2011
1LigandsIBA
07/2011
1N 30IBA
06/2010
1Trastuzumab (Herceptin)FDA Link
10/2007
1Biotin (Vitamin H)FDA Link
09/2003
1poly-d-lysineIBA
09/2003
1SuspensionsIBA
03/2003

Therapy/Procedure

23Radioimmunotherapy
04/2023 - 09/2003
22Therapeutics
04/2024 - 05/2002
9Aftercare (After-Treatment)
02/2020 - 11/2005
4Drug Therapy (Chemotherapy)
01/2023 - 07/2009
2Intravenous Injections
01/2021 - 01/2017
2Catheters
01/2019 - 07/2009
1Castration
02/2020
1Transcutaneous Electric Nerve Stimulation (TENS)
08/2013